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*Pseudomonas aeruginosa* is a ubiquitous environmental bacterium and an opportunistic pathogen causing acute and chronic infections in the urinary tract, blood, skin, and lungs of immunocompromised patients. *P. aeruginosa* strains and virulent variants causing severe human chronic infections, e.g., to the lungs of cystic fibrosis patients, have been extensively studied, while strains causing acute human infections need further investigation, primarily to define their pathogenic potential. In a previous study ([@B1]), we characterized the virulence phenotype of a collection of clinical *P. aeruginosa* strains that cause acute infections and identified the highly aggressive PA45 strain, a clinical isolate that caused a severe acute bloodstream infection in a hospitalized oncology patient who was undergoing chemotherapy treatment. Here, we report the draft genome sequence of the *P. aeruginosa* PA45 strain, thus providing new information about the genomic determinants underlying its highly aggressive phenotype.

The *P. aeruginosa* PA45 genome was sequenced using the 454 GS-FLX (Roche) platform, generating 854,562 raw reads, for a total of 332,906,173 bp with 50× average coverage (398 average read length). Using the Newbler 2.8 assembler, reads were assembled into 124 contigs with an N~50~ size of 220,690. Open reading frames, rRNAs, and tRNAs were identified and annotated using the pipeline provided by the Integrated Microbial Genomes-Expert Review ([@B2]). The genome is 6,615,955 bp long, exceeding the size of 9 of the 12 *P. aeruginosa* genomes available in the IMG database ([@B3]) (average 6,474,902 bp; standard deviation \[SD\], 226,090). The average G+C content is 66.3%, and 6,822 genes, including 3 rRNA and 58 tRNA genes, were identified. The annotation procedure successfully profiled 82.1% of genes with a specific function, 78.9% with a COG assignment, 48.77% with a KEGG orthology family, and 84.3% with Pfam domains. Of the 3,832 core genes shared by all 12 *P. aeruginosa* sequenced strains ([@B4]), 3,822 (99.7%) genes are found also in PA45, confirming the completeness of the core genome assembly and the presence of all functional modules characterizing this species. Compared to the accessory genome, which is unique to each of the already-sequenced strains, PA45 was found to be closely related to *P. aeruginosa* C3719 (GenBank accession no. NZ_AAKV00000000), carrying 74.4% of its unique genes (e-value, \<1e -- 20; length, \>200 bp), whereas *P. aeruginosa* NCGM2.S1 (GenBank accession no. AP012280) and *P. aeruginosa* 39016 (GenBank accession no. AEEX00000000) had the smallest number of overlapping strain-specific genes (20.8% and 23.0%, respectively). Compared to the other 12 *P. aeruginosa* strains, PA45 comprises the highest number of virulence genes (829) in its genome, according to the BLASTx translated search we performed against the Virulence Factor database (DB) ([@B5]). Focusing on the pathogenicity islands PAPI-1 and PAPI-2 carried by the highly virulent PA14 strain (GenBank accession no. NC_008463), 82 out of 113 PAPI-1 genes and 16 out of 19 PAPI-2 genes were found in PA45 (e-value, \<1e − 20). The unprecedented high abundance of virulence gene homologues carried by the PA45 strain correlates well with its highly aggressive phenotype.
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This Whole-Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. [APMD00000000](APMD00000000). The version described in this paper is the first version, accession no. [APMD01000000](APMD01000000).
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